WO2021155323A1 - Compositions and methods for preventing and treating coronavirus infection-sars-cov-2 vaccines - Google Patents

Compositions and methods for preventing and treating coronavirus infection-sars-cov-2 vaccines Download PDF

Info

Publication number
WO2021155323A1
WO2021155323A1 PCT/US2021/015946 US2021015946W WO2021155323A1 WO 2021155323 A1 WO2021155323 A1 WO 2021155323A1 US 2021015946 W US2021015946 W US 2021015946W WO 2021155323 A1 WO2021155323 A1 WO 2021155323A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
seq
sars
nucleic acid
cov
Prior art date
Application number
PCT/US2021/015946
Other languages
French (fr)
Inventor
Dan H. Barouch
Johannes Petrus Maria LANGEDIJK
Lucy RUTTEN
Mark Johannes Gerandus BAKKERS
Rinke Bos
Frank Wegmann
David Adrianus Theodorus Maria ZUIJDGEEST
An Vandebosch
Mathieu Claude Michel LE GARS
Jerald C. Sadoff
Original Assignee
Beth Israel Deaconess Medical Center, Inc.
Janssen Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US202062969008P priority Critical
Priority to US62/969,008 priority
Priority to US202062994630P priority
Priority to US62/994,630 priority
Priority to US63/014,467 priority
Priority to US202063014467P priority
Priority to US202063025782P priority
Priority to US63/025,782 priority
Priority to US202062705187P priority
Priority to US62/705,187 priority
Priority to US62/705,308 priority
Priority to US202062705308P priority
Priority to US63/043,090 priority
Priority to US202063043090P priority
Priority to US62/706,366 priority
Priority to US202062706366P priority
Priority to US63/066,147 priority
Priority to US202063066147P priority
Priority to US62/706,676 priority
Priority to US202062706676P priority
Priority to US202062706937P priority
Priority to US62/706,937 priority
Priority to US202062706958P priority
Priority to US62/706,958 priority
Priority to US202063198089P priority
Priority to US63/198,089 priority
Priority to US63/198,306 priority
Priority to US202063198306P priority
Priority to US202063112900P priority
Priority to US63/112,900 priority
Priority to CA3101131 priority
Priority to CA3101131A priority patent/CA3101131A1/en
Priority to US202063121482P priority
Priority to US63/121,482 priority
Priority to US202163133969P priority
Priority to US63/133,969 priority
Priority to US63/135,182 priority
Priority to US202163135182P priority
Priority to US63/141,913 priority
Priority to US202163141913P priority
Priority to US63/142,977 priority
Priority to US202163142977P priority
Application filed by Beth Israel Deaconess Medical Center, Inc., Janssen Pharmaceuticals, Inc. filed Critical Beth Israel Deaconess Medical Center, Inc.
Publication of WO2021155323A1 publication Critical patent/WO2021155323A1/en

Links